These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24736876)
21. Illness perceptions predict health practices and mental health following hematopoietic stem cell transplantation. Nelson AM; Juckett MB; Coe CL; Costanzo ES Psychooncology; 2019 Jun; 28(6):1252-1260. PubMed ID: 30942921 [TBL] [Abstract][Full Text] [Related]
22. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation]. Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395 [TBL] [Abstract][Full Text] [Related]
23. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse. Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Bregante S; Berisso G; Mordini N; Incagliato M; Fugazza G; Sessarego M; Bacigalupo A Haematologica; 1998 Oct; 83(10):896-903. PubMed ID: 9830798 [TBL] [Abstract][Full Text] [Related]
24. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680 [TBL] [Abstract][Full Text] [Related]
25. Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts. McDonald GB; Sandmaier BM; Mielcarek M; Sorror M; Pergam SA; Cheng GS; Hingorani S; Boeckh M; Flowers MD; Lee SJ; Appelbaum FR; Storb R; Martin PJ; Deeg HJ; Schoch G; Gooley TA Ann Intern Med; 2020 Feb; 172(4):229-239. PubMed ID: 31958813 [TBL] [Abstract][Full Text] [Related]
26. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates. Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074 [TBL] [Abstract][Full Text] [Related]
27. Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation. Ishikawa A; Otaka Y; Kamisako M; Suzuki T; Miyata C; Tsuji T; Matsumoto H; Kato J; Mori T; Okamoto S; Liu M Support Care Cancer; 2019 May; 27(5):1793-1800. PubMed ID: 30155567 [TBL] [Abstract][Full Text] [Related]
28. Impact of pre-transplant disease burden on the outcome of allogeneic hematopoietic stem cell transplant in refractory and relapsed acute myeloid leukemia: a single-center study. Tian H; Chen GH; Xu Y; Ma X; Chen F; Yang Z; Jin ZM; Qiu HY; Sun AN; Wu DP Leuk Lymphoma; 2015 May; 56(5):1353-61. PubMed ID: 25204372 [TBL] [Abstract][Full Text] [Related]
29. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network. Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J; J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420 [TBL] [Abstract][Full Text] [Related]
30. The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Friend BD; Bailey-Olson M; Melton A; Shimano KA; Kharbanda S; Higham C; Winestone LE; Huang J; Stieglitz E; Dvorak CC Pediatr Blood Cancer; 2020 Feb; 67(2):e28079. PubMed ID: 31724815 [TBL] [Abstract][Full Text] [Related]
31. Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival. El-Ghammaz AMS; Ben Matoug R; Elzimaity M; Mostafa N Support Care Cancer; 2017 Oct; 25(10):3085-3093. PubMed ID: 28439725 [TBL] [Abstract][Full Text] [Related]
32. Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT. Frankiewicz A; Peczynski C; Giebel S; Harrington A; Socié G; Niederwieser D; Scheid C; Bornhäuser M; Kröger N; Elmaagacli A; Afanasyev B; Dreger P; Rössig C; Blaise D; Kratz C; Yakoub-Agha I; Kremens B; Niemeyer CM; Wulf G; Blau I; Penack O; Greinix H; Basak GW Front Immunol; 2020; 11():1537. PubMed ID: 32793210 [TBL] [Abstract][Full Text] [Related]
33. Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation. Harashima S; Yoneda R; Horie T; Fujioka Y; Nakamura F; Kurokawa M; Yoshiuchi K Bone Marrow Transplant; 2019 Jul; 54(7):1013-1021. PubMed ID: 30353064 [TBL] [Abstract][Full Text] [Related]
34. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation. Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276 [TBL] [Abstract][Full Text] [Related]
35. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H Front Immunol; 2019; 10():1997. PubMed ID: 31507601 [TBL] [Abstract][Full Text] [Related]